These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 20194529)
1. Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. Akanuma S; Hosoya K; Ito S; Tachikawa M; Terasaki T; Ohtsuki S J Pharmacol Exp Ther; 2010 Jun; 333(3):912-9. PubMed ID: 20194529 [TBL] [Abstract][Full Text] [Related]
2. Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney. Ci L; Kusuhara H; Adachi M; Schuetz JD; Takeuchi K; Sugiyama Y Mol Pharmacol; 2007 Jun; 71(6):1591-7. PubMed ID: 17344354 [TBL] [Abstract][Full Text] [Related]
3. Transport of prostaglandin E1 across the blood-brain barrier in rats. Taogoshi T; Nomura A; Murakami T; Nagai J; Takano M J Pharm Pharmacol; 2005 Jan; 57(1):61-6. PubMed ID: 15638994 [TBL] [Abstract][Full Text] [Related]
4. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564 [TBL] [Abstract][Full Text] [Related]
5. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: involvement of an LRP-1-independent pathway. Ito S; Ueno T; Ohtsuki S; Terasaki T J Neurochem; 2010 Jun; 113(5):1356-63. PubMed ID: 20367755 [TBL] [Abstract][Full Text] [Related]
6. Inflammation-Induced Attenuation of Prostaglandin D Akanuma SI; Hashimoto K; Yoshida Y; Kubo Y; Hosoya KI Biol Pharm Bull; 2020; 43(11):1669-1677. PubMed ID: 33132311 [TBL] [Abstract][Full Text] [Related]
7. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier. Kikuchi R; Kusuhara H; Abe T; Endou H; Sugiyama Y J Pharmacol Exp Ther; 2004 Dec; 311(3):1147-53. PubMed ID: 15292460 [TBL] [Abstract][Full Text] [Related]
8. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853 [TBL] [Abstract][Full Text] [Related]
9. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544 [TBL] [Abstract][Full Text] [Related]
10. GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier. Takanaga H; Ohtsuki S; Hosoya Ki ; Terasaki T J Cereb Blood Flow Metab; 2001 Oct; 21(10):1232-9. PubMed ID: 11598501 [TBL] [Abstract][Full Text] [Related]
11. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Löscher W; Potschka H Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870 [TBL] [Abstract][Full Text] [Related]
12. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. Mori S; Ohtsuki S; Takanaga H; Kikkawa T; Kang YS; Terasaki T J Neurochem; 2004 Aug; 90(4):931-41. PubMed ID: 15287899 [TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. de Waart DR; Paulusma CC; Kunne C; Oude Elferink RP Liver Int; 2006 Apr; 26(3):362-8. PubMed ID: 16584400 [TBL] [Abstract][Full Text] [Related]
14. Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier. Ohtsuki S; Ito S; Matsuda A; Hori S; Abe T; Terasaki T J Neurochem; 2007 Nov; 103(4):1430-8. PubMed ID: 17868302 [TBL] [Abstract][Full Text] [Related]
15. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat. Isakovic AJ; Abbott NJ; Redzic ZB J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport. Gibbs JP; Adeyeye MC; Yang Z; Shen DD Epilepsy Res; 2004 Jan; 58(1):53-66. PubMed ID: 15066675 [TBL] [Abstract][Full Text] [Related]
17. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha. Lee NY; Kang YS Brain Res; 2004 Oct; 1023(1):141-7. PubMed ID: 15364029 [TBL] [Abstract][Full Text] [Related]
18. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202 [TBL] [Abstract][Full Text] [Related]
19. Selective brain to blood efflux transport of para-aminohippuric acid across the blood-brain barrier: in vivo evidence by use of the brain efflux index method. Kakee A; Terasaki T; Sugiyama Y J Pharmacol Exp Ther; 1997 Dec; 283(3):1018-25. PubMed ID: 9399971 [TBL] [Abstract][Full Text] [Related]
20. Kinetic evidence for active efflux transport across the blood-brain barrier of quinolone antibiotics. Ooie T; Terasaki T; Suzuki H; Sugiyama Y J Pharmacol Exp Ther; 1997 Oct; 283(1):293-304. PubMed ID: 9336336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]